Patents by Inventor Hui-Yuan Tseng

Hui-Yuan Tseng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of Pancreatic Cancer
    Publication number: 20230035723
    Abstract: The present disclosure provides methods of treating pancreatic cancer by administering a cationic liposomal formulation. Additional therapeutic agents or therapies may also be included.
    Type: Application
    Filed: February 24, 2022
    Publication date: February 2, 2023
    Applicant: SynCore Biotechnology Co., Ltd.
    Inventors: Ruey-Kuen Hsieh, Hui-Yuan Tseng, Sih-Ting Lin
  • TREATMENT OF BREAST CANCER
    Publication number: 20220313608
    Abstract: The present disclosure provides methods of treating breast cancer, including triple negative breast cancer. The methods disclosed herein comprise administering a cationic liposomal formulation containing one or more cationic lipids and a taxane to a subject in need thereof. The methods also include administering one or more non-liposomal formulations including one or more active agents.
    Type: Application
    Filed: March 21, 2022
    Publication date: October 6, 2022
    Applicants: SynCore Biotechnology Co., Ltd., CanCap Pharmaceutical Ltd.
    Inventors: Sih-Ting Lin, Hsin-Wei Teng, Hui-Yuan Tseng
  • TREATMENT OF PANCREATIC CANCER
    Publication number: 20190380994
    Abstract: A method of treating refractory or resistant pancreatic cancer by administering: (i) a cationic liposomal formulation comprising one or more cationic lipids and a therapeutically effective amount of paclitaxel; or (ii) a cationic liposomal formulation comprising one or more cationic lipids and a therapeutically effective amount of paclitaxel, and a therapeutically effective amount of gemcitabine.
    Type: Application
    Filed: January 4, 2018
    Publication date: December 19, 2019
    Applicant: SynCore Biotechnology Co., Ltd
    Inventors: Ruey-Kuen Hsieh, Hui-Yuan Tseng, Sih-Ting Lin
  • TREATMENT OF BREAST CANCER
    Publication number: 20190015332
    Abstract: The present disclosure provides methods of treating breast cancer, including triple negative breast cancer. The methods disclosed herein comprise administering a cationic liposomal formulation containing one or more cationic lipids and a taxane to a subject in need thereof. The methods also include administering one or more non-liposomal formulations including one or more active agents.
    Type: Application
    Filed: December 28, 2016
    Publication date: January 17, 2019
    Applicants: SynCore Biotechnology Co. Ltd., CanCap Pharmaceutical Ltd.
    Inventors: Sih-Ting Lin, Hsin-Wei Teng, Hui-Yuan Tseng